Filling the gaps to empower regional centres to manage myelodysplastic syndrome and acute myeloid leukaemia leading to wider cancer healthcare delivery and access to clinical trials
Internal Medicine Journal · 2025
DOI: 10.1111/imj.70011 ↗Kurz gefasst
Fallbericht in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Michael Ashby und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Services, Latrobe Regional Health, Traralgon, Victoria, Australia. Hauptthemen laut MEDLINE: Delivery of Health Care, Health Services Accessibility, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The management of patients with haematological malignancies in rural and regional Australia is different to that in metropolitan centres due to many factors. Lower‐intensity and easier‐to‐access treatments that are now available for acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) have improved the deliverability of treatment options for these disorders. Despite the challenges, urgent work is required to allow the care and outcomes of these patients to mirror those living in metropolitan centres.
Aims
To highlight the challenges in management of AML and MDS in regional Victoria.
Methods
Four clinical cases describing the difficulties faced in the management of AML/MDS patients in regional Victoria.
Results
We describe limitations in inpatient services, supportive care, blood product access and both specialised diagnostics and specialist workforce. Access to clinical trials is limited but vital to allow the availability of all therapeutic options.
Conclusions
Limitations in management of AML/MDS patients exist in regional centres. We utilised focused clinical fellows in a partnership between Latrobe Regional Health and Alfred Health in Victoria to improve treatment options for these patients. Moreover, we demonstrate future areas of focus, which will further enable rural and regional healthcare providers to bridge the gap in the care of patients with haematological malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cancer Services, Latrobe Regional Health, Traralgon, Victoria, Australia.
- Department of Clinical Haematology, Alfred Health, Melbourne, Victoria, Australia.
- Australian Centre for Blood Disease, Monash University, Melbourne, Victoria, Australia.
- TrialHub, Department of Research, Alfred Health, Melbourne, Victoria, Australia.
ORCID-Profile: Michael Ashby
Zitieren
APA
Ashby, M., Fleming, S., Spencer, A., Woollett, A., & Wright, T. (2025). Filling the gaps to empower regional centres to manage myelodysplastic syndrome and acute myeloid leukaemia leading to wider cancer healthcare delivery and access to clinical trials. Internal Medicine Journal. https://doi.org/10.1111/imj.70011
Vancouver
Ashby M, Fleming S, Spencer A, Woollett A, Wright T. Filling the gaps to empower regional centres to manage myelodysplastic syndrome and acute myeloid leukaemia leading to wider cancer healthcare delivery and access to clinical trials. Internal Medicine Journal. 2025. doi:10.1111/imj.70011
BibTeX
@article{Ashby2025,
author = {Ashby, Michael and Fleming, Shaun and Spencer, Andrew and Woollett, Anne and Wright, Tricia},
title = {Filling the gaps to empower regional centres to manage myelodysplastic syndrome and acute myeloid leukaemia leading to wider cancer healthcare delivery and access to clinical trials},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.70011}
}
EUVIMED